西点药业
(301130)
| 流通市值：17.09亿 | | | 总市值：22.37亿 |
| 流通股本：5841.31万 | | | 总股本：7649.47万 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 128,311,809.27 | 52,219,200.85 | 256,405,243.38 | 192,581,520.03 |
| 营业收入 | 128,311,809.27 | 52,219,200.85 | 256,405,243.38 | 192,581,520.03 |
| 二、营业总成本 | 104,512,163.74 | 45,150,013.49 | 219,405,403.1 | 160,706,213.91 |
| 营业成本 | 28,095,999.14 | 12,302,323.21 | 60,191,953.31 | 42,667,316.81 |
| 税金及附加 | 3,556,736.84 | 1,583,440.3 | 5,940,307.43 | 4,394,436.84 |
| 销售费用 | 48,168,309.18 | 19,808,305.01 | 121,085,464.02 | 84,092,570.97 |
| 管理费用 | 19,071,542.3 | 8,861,290.1 | 24,414,623.9 | 21,723,083.66 |
| 研发费用 | 5,673,710.96 | 2,646,289.2 | 10,224,075.45 | 10,025,178.8 |
| 财务费用 | -54,134.68 | -51,634.33 | -2,451,021.01 | -2,196,373.17 |
| 其中:利息费用 | 268,252.26 | 134,609.81 | 70,294.41 | 57,272.94 |
| 其中:利息收入 | 340,599.76 | 194,440.24 | 2,558,720.74 | 2,281,544.09 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 526,078.01 | 444,956.39 | 735,001.2 | 1,120,360.42 |
| 加:投资收益 | 1,115,374.4 | 390,898.01 | 4,263,802.43 | 2,767,345.52 |
| 资产处置收益 | - | - | -499,571.82 | - |
| 资产减值损失(新) | -56,416.51 | 7,904.73 | -609,336.95 | -471,032.23 |
| 信用减值损失(新) | -438,432.68 | -114,560.38 | -659,627.01 | -823,450.53 |
| 其他收益 | 1,977,212.89 | 1,063,688.8 | 6,104,473.97 | 5,205,516.81 |
| 四、营业利润 | 26,923,461.64 | 8,862,074.91 | 46,334,582.1 | 39,674,046.11 |
| 加:营业外收入 | 76.81 | 71.49 | 385,274.39 | 54.59 |
| 减:营业外支出 | 5,825.4 | - | 205,277.16 | 704,671.57 |
| 五、利润总额 | 26,917,713.05 | 8,862,146.4 | 46,514,579.33 | 38,969,429.13 |
| 减:所得税费用 | 3,440,726.65 | 1,210,197.44 | 6,245,780.6 | 4,902,896.89 |
| 六、净利润 | 23,476,986.4 | 7,651,948.96 | 40,268,798.73 | 34,066,532.24 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | - | 7,651,948.96 | 40,268,798.73 | 34,066,532.24 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 24,944,585.08 | 8,294,245.85 | 40,268,798.73 | 34,066,532.24 |
| 少数股东损益 | -1,467,598.68 | -642,296.89 | - | - |
| 扣除非经常损益后的净利润 | 23,386,006.42 | 7,567,590 | 34,746,419.71 | 28,885,686.6 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.33 | 0.11 | 0.52 | 0.44 |
| (二)稀释每股收益 | 0.33 | 0.11 | 0.52 | 0.44 |
| 九、综合收益总额 | 23,476,986.4 | 7,651,948.96 | 40,268,798.73 | 34,066,532.24 |
| 归属于母公司股东的综合收益总额 | 24,944,585.08 | 8,294,245.85 | 40,268,798.73 | 34,066,532.24 |
| 归属于少数股东的综合收益总额 | -1,467,598.68 | -642,296.89 | - | - |
| 公告日期 | 2025-08-15 | 2025-04-23 | 2025-04-23 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |